Cargando…

Type 2 Diabetes Mellitus (T2DM) and Carbohydrate Metabolism in Relation to T2DM from Endocrinology, Neurophysiology, Molecular Biology, and Biochemistry Perspectives

Type 2 diabetes mellitus (T2DM) is a severe disease caused by metabolic disorders, particularly carbohydrate metabolism disorders. The disease is a fatal global trouble characterised by high prevalence rates, causing death, blindness, kidney failure, myocardial infarction, amputation of lower limps,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mills, Hilla, Acquah, Ronald, Tang, Nova, Cheung, Luke, Klenk, Susanne, Glassen, Ronald, Pirson, Magali, Albert, Alain, Hoang, Duong Trinh, Van, Thang Nguyen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381199/ https://www.ncbi.nlm.nih.gov/pubmed/35983003 http://dx.doi.org/10.1155/2022/1708769

Ejemplares similares

Retracted: Type 2 Diabetes Mellitus (T2DM) and Carbohydrate Metabolism in Relation to T2DM from Endocrinology, Neurophysiology, Molecular Biology, and Biochemistry Perspectives
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Emergency Medicine with Advanced Surgery Protocols: A Review
por: Mills, Hilla, et al.
Publicado: (2022)

The Use of Bacteria in Cancer Treatment: A Review from the Perspective of Cellular Microbiology
por: Mills, Hilla, et al.
Publicado: (2022)

A Critical Scrutiny on Liposomal Nanoparticles Drug Carriers as Modelled by Topotecan Encapsulation and Release in Treating Cancer
por: Mills, Hilla, et al.
Publicado: (2022)

Preparation of PCL Electrospun Fibers Loaded with Cisplatin and Their Potential Application for the Treatment of Prostate Cancer
por: Mills, Hilla, et al.
Publicado: (2022)

Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD)
por: Mills, Hilla, et al.
Publicado: (2022)

Commentary: Computational Analysis for ERAS and Other Surgical Processes: Commentary From Clinical Perspective
por: Mills, Hilla, et al.
Publicado: (2022)

I-14 Molecular pathomechanism of DM2/PROMM: similarities and differences between DM1 and DM2
por: Meola, G.
Publicado: (2011)

T2DM: Why Epigenetics?
por: Fradin, Delphine, et al.
Publicado: (2011)

T2DM patients with depression have higher levels of hyperglycemia and cognitive decline than T2DM patients
por: Thummasorn, Savitree, et al.
Publicado: (2022)

Less Is Better: Single-Digit Brain Functional Connections Predict T2DM and T2DM-Induced Cognitive Impairment
por: Qian, Haotian, et al.
Publicado: (2021)

DM-Ice
por: Seo, Seon-Hee
Publicado: (2011)

The contribution of genetic variants of SLC2A1 gene in T2DM and T2DM-nephropathy: association study and meta-analysis
por: Stefanidis, I., et al.
Publicado: (2018)

Assessing MicroRNA-375 Levels in Type 2 Diabetes Mellitus (T2DM) Patients and Their First-Degree Relatives with T2DM
por: Wu, Xu, et al.
Publicado: (2021)

Hyperuricaemia and the metabolic syndrome in type 2 DM
por: Ogbera, Anthonia O, et al.
Publicado: (2010)

HER2 expression and efficacy of T-DM1
por: Montemurro, Filippo
Publicado: (2014)

SP prevents T2DM complications by immunomodulation
por: Baek, Sang-Min, et al.
Publicado: (2020)

Reversal and Remission of T2DM – An Update for Practitioners
por: Shibib, Lina, et al.
Publicado: (2022)

Oxidative stress parameters and keap 1 variants in T2DM: Association with T2DM, diabetic neuropathy, diabetic retinopathy, and obesity
por: Khalili, Farnaz, et al.
Publicado: (2021)

A Review of Economic Models Submitted to NICE’s Technology Appraisal Programme, for Treatments of T1DM & T2DM
por: Daly, Marie-Josée, et al.
Publicado: (2022)

The Nile Rat (Arvicanthis niloticus) as a Superior Carbohydrate-Sensitive Model for Type 2 Diabetes Mellitus (T2DM)
por: Subramaniam, Avinaash, et al.
Publicado: (2018)

Comorbidity Analysis between Alzheimer’s Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs
por: Karki, Reagon, et al.
Publicado: (2017)

Consequences of DM/antiDM Oscillations for Asymmetric WIMP Dark Matter
por: Cirelli, Marco, et al.
Publicado: (2011)

Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM?
por: Kloc, Małgorzata, et al.
Publicado: (2020)

Whether or Not the Effects of Curcuma longa Supplementation Are Associated with Physical Exercises in T1DM and T2DM: A Systematic Review
por: Sena-Júnior, Ailton Santos, et al.
Publicado: (2020)

Burden of T1DM and T2DM among adolescents in Western Europe, 1990-2019: results from the GBD 2019
por: Armocida, B, et al.
Publicado: (2023)

DM at the LHC, an overview
por: Wang, Renjie
Publicado: (2019)

The ArDM experiment
por: Haranczyk, M, et al.
Publicado: (2010)

Searches for DM with ATLAS
por: Gonzalez Fernandez, Sergio
Publicado: (2020)

DM Authors no. 8
Publicado: (1977)

Type 2 DM is not coronary artery disease equivalent
por: Ayyar, Vageesh S.
Publicado: (2012)

Examining W, g-2, and DM anomalies with the NMSSM
por: Tsai, YUE-LIN
Publicado: (2022)

Yoga: Managing overweight in mid-life T2DM
por: Tikhe, Ashwini Sham, et al.
Publicado: (2015)

CMB spectral distortions as a probe of DM-$\gamma$ and DM-$\nu$ interactions
por: Diacoumis, James
Publicado: (2018)

The Prevalence and Outcome of pre-DM/DM in an Urban HIV Primary Care Clinic
por: Jeong, Young-Gwang, et al.
Publicado: (2017)

Gut microbiota influence in type 2 diabetes mellitus (T2DM)
por: Cunningham, A. L., et al.
Publicado: (2021)

Editorial: Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
por: Luo, Jian-Quan, et al.
Publicado: (2023)

Dietary Knowledge, Attitude and Practice (KAP) Among the Family Members of Patients with Type 2 Diabetes Mellitus (T2DM) and Its Influence on the KAP of T2DM Patients
por: Hu, Xiling, et al.
Publicado: (2021)

Demographical, Clinical, and Psychological Characteristics of Users and Nonusers of an Online Platform for T2DM Patients (e-VitaDM-3/ZODIAC-44)
por: Roelofsen, Yvonne, et al.
Publicado: (2016)

Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies
por: Ray, Kausik K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dov5612ksf6k4umujl835sckqn